Array Technologies, Inc. Reports Financial Results for the Second Quarter 2024 – Delivers strong results on continued gross margin strength
Go back to Array Technologies, Inc. Reports Financial Results for the Second Quarter 2024 – Delivers strong results on continued gross margin strength| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 8.26 -0.28 (3.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.54 | 52 Week High | $7.27 | |||
| Open | $8.17 | 52 Week Low | $2.39 | |||
| Day High | $8.38 | P/E | N/A | |||
| Day Low | $8.11 | EPS | $-0.61 | |||
| Volume | 1,831,134 | |||||
